VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $31,000 | -65.2% | 19,212 | -48.3% | 0.00% | – |
Q2 2021 | $89,000 | +21.9% | 37,161 | -3.9% | 0.00% | – |
Q4 2020 | $73,000 | -75.4% | 38,666 | -83.4% | 0.00% | – |
Q2 2020 | $297,000 | +1647.1% | 232,264 | +1773.4% | 0.00% | – |
Q1 2020 | $17,000 | -79.5% | 12,398 | -8.6% | 0.00% | – |
Q3 2017 | $83,000 | -27.2% | 13,565 | -42.5% | 0.00% | – |
Q4 2016 | $114,000 | +56.2% | 23,600 | +67.8% | 0.00% | – |
Q3 2016 | $73,000 | -36.0% | 14,061 | -43.2% | 0.00% | – |
Q2 2016 | $114,000 | -89.3% | 24,772 | -87.8% | 0.00% | -100.0% |
Q4 2015 | $1,069,000 | – | 203,211 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 896,771 | $2,063,000 | 2.12% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $230,000 | 0.14% |
683 Capital Management, LLC | 400,000 | $920,000 | 0.08% |
DLD Asset Management, LP | 244,500 | $555,000 | 0.05% |
ARK Investment Management | 75,354 | $173,000 | 0.01% |
Virtu Financial LLC | 68,222 | $157,000 | 0.01% |
IFP Advisors, Inc | 19,567 | $139,000 | 0.01% |
FIDUCIARY TRUST INTERNATIONAL LLC | 11,050 | $25,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 19,614 | $43,000 | 0.00% |
A.R.T. Advisors, LLC | 37,782 | $86,000 | 0.00% |